Skip to main content
Aligned Genetics, Inc. logo

Aligned Genetics, Inc. — Investor Relations & Filings

Ticker · 238120 ISIN · KR7238120000 KO Manufacturing
Open in API
Filings indexed 140 across all filing types
Latest filing 2026-03-31 Declaration of Voting R…
Country KR South Korea
Listing KO 238120

About Aligned Genetics, Inc.

https://en.alignedgenetics.com

Aligned Genetics, Inc. is a company that develops, manufactures, and sells advanced solutions for cellular imaging, biomolecular analysis, and molecular diagnostics. It provides cutting-edge equipment, automated systems, imaging instruments, and reagents for laboratories in the life science and medical fields. The company focuses on developing molecular diagnostic solutions that deliver rapid and accurate results to support faster clinical care. Aligned Genetics aims to improve human health by creating technologies that offer deeper insights into cellular and molecular processes.

Recent filings

Filing Released Lang Actions
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled “정기주주총회 결과” (Results of the Annual General Meeting) and contains detailed vote outcomes for each resolution, dividend resolutions, election of auditors, and shareholder meeting particulars. It is not a notice of meeting or proxy solicitation but the official published results of a general meeting’s agenda. This matches the definition for Declaration of Voting Results & Voting Rights Announcements (Code DVA).
2026-03-31 Korean
본점소재지변경
Regulatory Filings Classification · 1% confidence The document is a Korean stock exchange filing announcing a change in the company’s registered head office address (본점소재지변경), including old and new addresses, reason, effective date, and board resolution date. It does not report financial results, management changes, dividends, share issues, or detailed financial statements. It is a regulatory announcement of a corporate administrative change, which does not fit a more specific category, so it falls under the fallback category Regulatory Filings (RNS).
2026-03-31 Korean
사업보고서 (2025.12)
Audit Report / Information Classification · 1% confidence The document contains an independent auditor’s report (‘감사보고서’) by 삼일회계법인, including an audit opinion, auditor responsibilities, key audit matters, and full financial statements with notes. It is a standalone audit report rather than an annual report announcement or a short notice. It matches the definition of an Audit Report / Information (AR). FY 2025
2026-03-23 Korean
감사보고서제출
Audit Report / Information Classification · 1% confidence The document is a regulatory filing from a Korean company (Aligned) titled 'Audit Report Submission' (감사보고서 제출). It provides the auditor's opinion (unqualified/appropriate), key financial data (assets, liabilities, equity, revenue, profit), and details regarding the audit process. While it contains financial data, it is a formal regulatory announcement of the audit report's submission to the exchange, rather than the full annual report (10-K) or a standalone audit report document. Given the structure and the nature of the disclosure, it fits the 'Report Publication Announcement' (RPA) category as it announces the filing of the audit results. FY 2025
2026-03-19 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Aligned Genetics. It contains the meeting agenda, details on voting, and management information, which are standard components of a Proxy Solicitation & Information Statement. While it includes financial data, this is provided as part of the 'management reference materials' required for shareholders to vote on the approval of financial statements, rather than being an independent Annual Report or Earnings Release. Therefore, it is classified as a Proxy Solicitation & Information Statement.
2026-03-16 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by Aligned Genetics. It outlines the date, location, agenda items (such as financial statement approval, articles of incorporation changes, and auditor appointment), and details regarding the meeting. This document serves as the official proxy solicitation and information statement provided to shareholders to inform them of the upcoming meeting and the matters to be voted upon.
2026-03-16 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.